In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: PVSG-10
2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-875001, MAYO-875001, NCCTG-87-50-01
3.

Phase: Phase III
Type: Prevention
Status: Completed
Age: over 30 to under 75
Sponsor: NCI, Other
Protocol IDs: CDR0000078380, CLB-9270, E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527
4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BARTS-DAVDAS, EU-20610, ISRCTN13255144, NCT00316927
5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000491649, OCTO-003, EUDRACT-2004-003836-77, ISRCTN85156844, EU-20628, OCTO-ASPECT, RADCLIFFE-32, ZENECA-RADCLIFFE-32, NCT00357682
6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000404161, ECOG-E4A03, E4A03, NCT00098475
7.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: 69, R01HL043851, HL043851, CA047988, NCT00000479
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8802D, NCI-88-C-84D, NCI-T88-0103N, T88-0103
9.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-00-C-0128, MB-401, NCI-T99-0066, T99-0066, NCT00020189
10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-851901, NCI-T85-0264D, T85-0264
11.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-DS-8816, NCI-V88-0553
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-0427 / 201107340, NCT00263211
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-MAY04-4-01, MAY04-4-01, NCT00474903
14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-PI-0103, 07/04, NCT00482261
15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: NCI 04-2-03, NU-NWU04-2-03, NWU04-2-03, NCT00468910
16.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CCUM-9215, NCI-P93-0040
17.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7803
18.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 21 to 80
Sponsor: NCI
Protocol IDs: DMS-CPHS-10293, NCI-P95-0063
19.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: PVSG-5
20.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: QMC-UKCAP, EU-20045, NCT00033319
21.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 45 to 74
Sponsor: Other
Protocol IDs: 01426-V, 05-7956-V 01, 28526-V, NCT00234299
22.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 to 95
Sponsor: Other
Protocol IDs: V0801, NCT00727948
23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 55 to 75
Sponsor: NCI, Other
Protocol IDs: PHS 1908.00, FHCRC-PHS-1908.00, FHCRC-1908, CDR0000544639, NCT00470561
New Search